Streptomyces clavuligerus
Streptomyces clavuligerus | |
---|---|
Scientific classification | |
Kingdom: | Bacteria |
Phylum: | Actinobacteria |
Order: | Actinomycetales |
Family: | Streptomycetaceae |
Genus: | Streptomyces |
Species: | S. clavuligerus |
Binomial name | |
Streptomyces clavuligerus Higgens & Kastner 1971 | |
Streptomyces clavuligerus is a species of Gram-positive bacterium that produces clavulanic acid.[1]
S. clavuligerus ATCC 27064 (NRRL 3585, DSM 738) was first described by Higgens and Kastner, who isolated it from a South American soil sample.[2] Its name refers to the shape of its spore-bearing hyphal branches: from the Latin, clavula, meaning little club, and igerus, meaning bearing. S. clavuligerus spores are gray to grayish-green.[2]
S. clavuligerus produces over 20 secondary metabolites, including many beta-lactam antibiotics such as clavulanic acid, cephamycin C, deacetoxycephalosporin C, penicillin N (an intermediate in cephamycin C pathway), and at least four other clavams.[3][4] Non-β-lactam antibiotics include holomycin and an antibiotic complex, MM 19290, related to tunicamycin;[5] a beta-lactamase-inhibitory protein (BLIP) has also been described.[6]
Another important characteristic of S. clavuligerus is that it is not able to use glucose as a carbon source because it lacks a glucose transport system.[7][8]
It also possesses all the enzymes of the urea cycle, which is unusual for a prokaryote, although it is not clear whether the urea cycle is functional.[9]
References
- ↑ Reading C, Cole M (1977). "Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus". Antimicrob Agents Chemother 11 (5): 852–7. PMC 352086. PMID 879738.
- ↑ 2.0 2.1 Higgens CE, Kastner RE (1971). "Streptomyces clavuligerus sp. nov., a beta-lactam antibiotic producer". International Journal of Systematic Bacteriology 21 (4): 326–31. doi:10.1099/00207713-21-4-326.
- ↑ Nabais AMA, Dafonseca MMR (1995). "The Effect of Solid Medium Composition on Growth and Sporulation of Streptomyces-Clavuligerus - Spore Viability During Storage at +4-Degrees-C". Biotechnology Techniques 9 (5): 361–4. doi:10.1007/BF00638871.
- ↑ Tahlan K, Anders C, Jensen S (2004). "The Paralogous Pairs of Genes Involved in Clavulanic Acid and Clavam Metabolite Biosynthesis Are Differently Regulated in Streptomyces clavuligerus". J Bacteriol 186 (18): 6286–97. doi:10.1128/JB.186.18.6286-6297.2004. PMC 515150. PMID 15342599.
- ↑ Baggaley K, Brown A, Schofield C (1997). "Chemistry and biosynthesis of clavulanic acid and other clavams". Nat Prod Rep 14 (4): 309–33. doi:10.1039/np9971400309. PMID 9281835.
- ↑ Doran J, Leskiw B, Aippersbach S, Jensen S (1990). "Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene". J Bacteriol 172 (9): 4909–18. PMC 213145. PMID 2203736.
- ↑ Aharonowitz Y, Demain A (1 August 1978). "Carbon Catabolite Regulation of Cephalosporin Production in Streptomyces clavuligerus". Antimicrob Agents Chemother 14 (2): 159–64. PMC 352426. PMID 697343.
- ↑ Garcia-Dominguez M, Martin J, Liras P (1989). "Characterization of sugar uptake in wild-type Streptomyces clavuligerus, which is impaired in glucose uptake, and in a glucose-utilizing mutant". J Bacteriol 171 (12): 6808–14. PMC 210580. PMID 2687256.
- ↑ Kirk S (2000). The physiology of clavulanic acid production by Streptomyces clavuligerus (PhD thesis). University of Surrey, UK.
External links
- "Taxonomy Browser (Streptomyces clavuligerus)". NCBI. Retrieved 2006-08-16.